Unit 7 Discussion Diabetes Treatment. 1000w. due4-19-24

profilefdsa123
Unit7DiscussionDiabetesTreatment.1000w.due4-19-24.docx

Unit 7 Discussion Diabetes Treatment. 1000w. due4-19-24

You have a newly diagnosed, type 2 diabetic, 16-year-old female in your clinic. The patient is the goalie of her high school soccer team.  Her BMI is 37

1. Your treatment plan for the new diagnosis of type 2 diabetes – structure your plan using the format outlined in the SOAP note assignment instructions (e.g. diagnostics, therapeutics, educational, consultation/collaboration)

2. Citations for each of the evidence-based practice (EBP) interventions included in your plan

3. For each article, you cited in support of an element of the plan, provide your thoughts about the strength of the evidence presented in the article(s)

Please be sure to validate your opinions and ideas with citations and references in APA format.

Use information below and attached book.

Unit 7 Discussion Diabetes Treatment

You have a newly diagnosed, type 2 diabetic, 16-year-old female in your clinic. The patient is the goalie of her high school soccer team. Her BMI is 37.

Assessment:1.New onset of Type 2 Diabetes

2.ObesityPlan: Type 2 DiabetesDiagnostics:HgbA1CCBCUrine Microalbumin Therapeutics: Initiation of diabetes medication Educational: Glycemic Control Blood sugar monitoring Healthy eating Consultation/Collaboration: Referral to Endocrinology Referral to Dietician for Diabetic EducationPlan: Obesity Diagnostics: CBCCMPLipid panel

Therapeutics: Educational: Healthy eating Regular exercise Weight loss Consultation/Collaboration: Referral to Dietician The American Diabetes Association standards of care include the some of most current evidence-based recommendations for diagnosing and treating all ages with any type of diabetes. Some of the standards of care include pharmacologic

Unit 7 Discussion – Diabetes Treatment

Subjective (S): A 16-year-old female patient presents to the clinic, and her chief complaint

involves newly diagnosed type 2 diabetes. The social history reveals she engages in sports and

serves as a goalie for her high school soccer team.

Objective (O): The vital signs as revealed in the case study or description suggest a BMI of 37.

Assessment (A): The patient’s assessment results indicate she has type 2 diabetes.

Plan (P):

Therapeutics: The case description reveals type 2 diabetes in a youthful individual, pointing to

the need for a multifaceted intervention. The primary goal would be to mitigate possible

complications, ensure glycemic control, counter insulin resistance associated with the condition,

and address the failure of β-cell. In particular, a multifaceted intervention for such a patient calls

for the combination of Pharmacotherapeutics and adjustments in the patient’s family-based

behavioral habits (Cioana, Deng & Hou et al., 2021). The literature also suggests that the chief

purpose of intervention for youths with type 2 diabetes should involve preventing further weight

loss of weight gain, controlling potential comorbidities, ensuring glycemia is normalized, and

advocating for healthier lifestyle behaviors (Himalowa, Banda & Mweshi et al., 2020). For this

patient, some of the comorbidities that need to be controlled and that are associated with type 2

diabetes include nephropathy, dyslipidemia, hypertension, and hepatic steatosis.

Pharmacotherapeutics ought to involve using metformin. The FDA has approved the oral use of

metformin for youth type-2 diabetes because of its capacity to bring about significant reductions

in HbA1c, especially after it is used for about four months. According to Cioana, Deng and Hou et al. (2021), metformin’s beneficial effects outweigh those gained from placebo, whereby values

of fasting plasma glucose improvement stand at 2.4 mmol/L and 1.2 mmol/L, respectively. As

such, metformin is recommended for this patient because it comes with fewer side effects,

having proved its efficacy when used as the oral anti-diabetic drug for youth type 2 diabetes.

Similarly, insulin therapy is ideal for this patient because it has been associated with significant

reductions in HbA1c among youths diagnosed with type-2 diabetes (Himalowa, Banda & Mweshi

et al., 2020).

The above-mentioned approaches are Pharmacotherapeutics. When it comes to the approach

entailing lifestyle modification, it is necessary that the nutritional and activity behaviors of the

patient are targeted. According to Cioana, Deng and Hou et al. (2021), specific lifestyle

modification interventions ideal for youths with type-2 diabetes include reducing the intake high

in calories, fats, and beverages containing sugar, establishing regular meal schedules and

controlling the portion sizes, and the overall improvement in one’s food choices.

Educational: Insulin therapy comes with some risks, such as increased weight and

hypoglycemia (Himalowa, Banda & Mweshi et al., 2020). Therefore, the patient will be educated

about these side effects. Additionally, the patient will be educated regarding the beneficial effects

of abiding by the recommended medication schedules and injections. It is also notable that

lifestyle adjustments involving processes such as walking and reducing screen time come with

certain SMART goals, and so the patient will need to be educated about lifestyle adjustment

techniques that might provide room for the achievement of those goals.

Collaboration/Consultation: The therapeutic intervention will be accompanied by ongoing

monitoring. If the symptoms are found to worsen, it will be key to refer the patient to an endocrinologist to assess the situation further and recommend alternative and more advanced

interventions that could bring about outcome improvement.

Evidence Strength

The two articles by Cioana, Deng and Hou et al. (2021) and Himalowa, Banda and

Mweshi et al. (2020) were conducted and produced from the perspectives of systematic reviews.

To produce systematic reviews, researchers or reviewers consider all the available evidence and

summarize the findings before disseminating the results and their associated reliability and

validity to the target audiences. Therefore, it can be inferred that these two articles were more

likely to be transparent, and their reports constitute the best evidence. In the hierarchy pyramid

depicting the levels of strength of research studies, systematic reviews are ranked at the fifth

level, pointing to the selected studies’ remarkable strength that makes their recommendations for

the EBP interventions worth relying upon.

References

Cioana, M., Deng, J., & Hou, M. et al. (2021). Prevalence of Hypertension and Albuminuria in

Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Netw Open,

4(4):e216069. doi:10.1001/jamanetworkopen.2021.6069

Himalowa, S., Banda, M. & Mweshi, M. et al. (2020). Strategies to Prevent Type 2 Diabetes

Mellitus among School Children: A Systematic Review. Research in Health Science, 5(2),

64-77 DOI: 10.22158/rhs.v5n2p64